- CA$223.35m
- CA$276.35m
- CA$291.20m
- 45
- 74
- 83
- 75
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.1 | 3.4 | 4 | 13 | 291 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 65.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 46 | 23.6 | 25.8 | 31.1 | 429 |
Operating Profit | -37.9 | -20.2 | -21.8 | -18.1 | -137 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 84.3 | -10.2 | -12.1 | 445 | -181 |
Provision for Income Taxes | |||||
Net Income After Taxes | 65.1 | -15.1 | -17.1 | 440 | -189 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,112 | -4.1 | -16.4 | 440 | -188 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,116 | -16.8 | -29 | 428 | -201 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.54 | -0.299 | -0.327 | 4.96 | -2.15 |
Dividends per Share |